Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

164 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.
Qureshi SA, Rios Candelore M, Xie D, Yang X, Tota LM, Ding VD, Li Z, Bansal A, Miller C, Cohen SM, Jiang G, Brady E, Saperstein R, Duffy JL, Tata JR, Chapman KT, Moller DE, Zhang BB. Qureshi SA, et al. Diabetes. 2004 Dec;53(12):3267-73. doi: 10.2337/diabetes.53.12.3267. Diabetes. 2004. PMID: 15561959
Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.
Jiang G, Dallas-Yang Q, Li Z, Szalkowski D, Liu F, Shen X, Wu M, Zhou G, Doebber T, Berger J, Moller DE, Zhang BB. Jiang G, et al. Diabetes. 2002 Aug;51(8):2412-9. doi: 10.2337/diabetes.51.8.2412. Diabetes. 2002. PMID: 12145152
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.
Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL, Kharitonenkov A, Bumol T, Schilske HK, Moller DE. Gaich G, et al. Among authors: moller de. Cell Metab. 2013 Sep 3;18(3):333-40. doi: 10.1016/j.cmet.2013.08.005. Cell Metab. 2013. PMID: 24011069 Free article. Clinical Trial.
Fibroblast growth factor 21 corrects obesity in mice.
Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A. Coskun T, et al. Endocrinology. 2008 Dec;149(12):6018-27. doi: 10.1210/en.2008-0816. Epub 2008 Aug 7. Endocrinology. 2008. PMID: 18687777
Transcriptional and blood cytokine profiling studies revealed effects consistent with the ability of FGF21 to ameliorate insulin and leptin resistance, enhance fat oxidation and suppress de novo lipogenesis in liver as well as to activate futile cycling in adipose. ...
Transcriptional and blood cytokine profiling studies revealed effects consistent with the ability of FGF21 to ameliorate insulin and leptin …
FGF21-based pharmacotherapy--potential utility for metabolic disorders.
Gimeno RE, Moller DE. Gimeno RE, et al. Among authors: moller de. Trends Endocrinol Metab. 2014 Jun;25(6):303-11. doi: 10.1016/j.tem.2014.03.001. Epub 2014 Apr 5. Trends Endocrinol Metab. 2014. PMID: 24709036 Review.
Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.
Kusunoki J, Kanatani A, Moller DE. Kusunoki J, et al. Endocrine. 2006 Feb;29(1):91-100. doi: 10.1385/ENDO:29:1:91. Endocrine. 2006. PMID: 16622296 Review.
Increased de novo lipogenesis and reduced fatty acid oxidation are probable contributors to adipose accretion in obesity. Moreover, these perturbations have a role in leading to non-alcoholic steatohepatitis, dyslipidemia, and insulin resistance--via "lipotoxicity"-related …
Increased de novo lipogenesis and reduced fatty acid oxidation are probable contributors to adipose accretion in obesity. Moreover, t …
Metabolic syndrome: a clinical and molecular perspective.
Moller DE, Kaufman KD. Moller DE, et al. Annu Rev Med. 2005;56:45-62. doi: 10.1146/annurev.med.56.082103.104751. Annu Rev Med. 2005. PMID: 15660501 Review.
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB. Mu J, et al. Diabetes. 2006 Jun;55(6):1695-704. doi: 10.2337/db05-1602. Diabetes. 2006. PMID: 16731832
Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson.
Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G. Lawrence JW, et al. J Biol Chem. 2001 Aug 24;276(34):31521-7. doi: 10.1074/jbc.M103306200. Epub 2001 Jun 19. J Biol Chem. 2001. PMID: 11418601
164 results
Jump to page
Feedback